
Why Insiders Aren’t Shying Away from Big-Ticket Stocks Like Merck
Insiders are increasingly drawn to high-priced stocks, with Merck & Co., Inc. (MRK) as a notable example. Merck’s diverse healthcare innovations, spanning oncology and veterinary medicine, attract significant insider investment. Despite Merck’s stock decline of 11.55% this year and 31.31% over 12